文献速递生殖医学妇科

化疗性卵巢性腺毒性与性腺保护:叙述性综述

Ovarian gonadotoxicity and gonadoprotection: a narrative review.
PubMed 文献 · Reprod Biomed Online · 2026-07-31

本文为叙述性综述,总结化疗对卵巢储备的多因素损伤机制及临床前性腺保护策略。化疗可诱导卵泡凋亡、过度激活原始卵泡及间质损伤;临床前研究探索抑制凋亡通路、抑制卵泡激活及保护卵巢间质等策略,结果令人鼓舞但尚需进一步研究方可安全用于临床。

要点

  • 化疗通过卵泡凋亡、原始卵泡过度激活耗竭及间质损伤等多因素损伤卵巢储备。
  • 临床前保护策略包括抑制凋亡通路、抑制卵泡激活及保护卵巢间质。
  • 现有性腺保护方法多处于临床前阶段,尚需进一步研究验证安全性和临床适用性。

核心结论

  • 化疗对卵巢的性腺毒性机制是多因素的,临床前性腺保护策略结果令人鼓舞但尚需进一步研究才能安全用于临床。

研究设计与样本

  • 叙述性综述,旨在更新化疗对卵巢的影响并总结当前及新兴的性腺保护策略。

主要发现

  • 化疗可诱导生长卵泡和原始卵泡凋亡,并引起原始卵泡过度激活,导致卵巢储备耗竭。
  • 间质损伤可能进一步加重化疗对卵巢的损伤效应。
  • 临床前研究通过抑制特定通路介质(酪氨酸激酶抑制剂、丝氨酸/苏氨酸激酶抑制剂、鞘脂类)或使用间充质干细胞衍生因子、特定microRNA和抗氧化分子来靶向卵泡凋亡以保护卵巢。
  • 其他研究通过靶向直接通路(如磷脂酰肌醇3-激酶和哺乳动物雷帕霉素靶蛋白调节剂)或间接调节因子(如抗苗勒管激素)抑制卵泡激活。
  • 部分方法旨在保护卵巢间质,这对保留卵巢功能可能至关重要。

临床怎么用

  • 临床应认识到化疗对卵巢储备的多因素损伤,关注儿童及育龄女性癌症幸存者的生育力保护需求。
  • 现有性腺保护策略多处于临床前研究阶段,临床应用中应谨慎评估其安全性和适用性。

局限性

  • 综述未报告具体研究样本量、效应量及统计学指标。
  • 所总结的性腺保护策略多来自临床前研究,尚缺乏临床安全性和有效性证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chemotherapy-induced gonadotoxicity is a serious concern for cancer survivors, particularly children and women of reproductive age. The mechanisms by which chemotherapy depletes the ovarian reserve and impairs fertility are multifactorial. Chemotherapy can induce apoptosis of growing and primordial follicles, as well as excessive activation of primordial follicles, leading to burnout of the ovarian reserve. Stromal damage may further exacerbate these effects. Preclinical studies have aimed to safeguard the ovary against chemotherapy by targeting follicular apoptosis through inhibition of specific pathway mediators (tyrosine kinase inhibitors, serine/threonine kinase inhibitors, sphingolipids) or use of mesenchymal-stem-cell-derived factors, specific microRNA and antioxidant molecules. Other studies have focused on inhibiting follicular activation by targeting direct pathways (e.g. phosphatidylinositol 3-kinase and mammalian target of rapamycin modulators) or indirect regulators (e.g. anti-Müllerian hormone). Finally, some approaches aim to protect the ovarian stroma, which may be crucial to preserving ovarian function. The objective of this article is to provide an updated overview of the effects of chemotherapy on the ovary, and summarize current and emerging gonadoprotective strategies. Although numerous preclinical studies have reported encouraging results, further research is needed before these approaches can be considered safe and suitable for clinical application.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Houeis L, Donnez J, Dolmans MM, et al. Ovarian gonadotoxicity and gonadoprotection: a narrative review. Reprod Biomed Online. 2026. PMID: 42604621. doi:10.1016/j.rbmo.2026.105891

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。